![Human IFN-κ Inhibited Respiratory RNA Virus Replication Dependent on Cell-to-Cell Interaction in the Early Phase | Infectious Diseases & Immunity Human IFN-κ Inhibited Respiratory RNA Virus Replication Dependent on Cell-to-Cell Interaction in the Early Phase | Infectious Diseases & Immunity](https://mednexus.org/cms/asset/99a754e2-a567-49c0-bd68-6b2e04e78512/id9.0000000000000049.png)
Human IFN-κ Inhibited Respiratory RNA Virus Replication Dependent on Cell-to-Cell Interaction in the Early Phase | Infectious Diseases & Immunity
![Emerging concepts of type I interferons in SLE pathogenesis and therapy | Nature Reviews Rheumatology Emerging concepts of type I interferons in SLE pathogenesis and therapy | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41584-022-00826-z/MediaObjects/41584_2022_826_Fig1_HTML.png)
Emerging concepts of type I interferons in SLE pathogenesis and therapy | Nature Reviews Rheumatology
![Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies | PNAS Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies | PNAS](https://www.pnas.org/cms/10.1073/pnas.2205983119/asset/2947487e-06b0-418b-b2cf-f1a8b04274c0/assets/images/large/pnas.2205983119fig01.jpg)
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies | PNAS
![Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41590-019-0466-2/MediaObjects/41590_2019_466_Fig1_HTML.png)
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
![Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine](https://lupus.bmj.com/content/lupusscimed/6/1/e000270/F1.large.jpg)
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
![Frontiers | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms Frontiers | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms](https://www.frontiersin.org/files/Articles/450667/fimmu-10-01425-HTML-r1/image_m/fimmu-10-01425-g001.jpg)
Frontiers | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms
![Interferon‐γ: an overview of signals, mechanisms and functions - Schroder - 2004 - Journal of Leukocyte Biology - Wiley Online Library Interferon‐γ: an overview of signals, mechanisms and functions - Schroder - 2004 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/cbd9b4ba-8a5a-4974-87d2-5ba6a840a230/jlb0163-fig-0001-m.jpg)
Interferon‐γ: an overview of signals, mechanisms and functions - Schroder - 2004 - Journal of Leukocyte Biology - Wiley Online Library
![IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases](https://www.mdpi.com/ijms/ijms-22-11286/article_deploy/html/images/ijms-22-11286-g001.png)
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
![Frontiers | Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases Frontiers | Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases](https://www.frontiersin.org/files/Articles/1008072/fimmu-13-1008072-HTML/image_m/fimmu-13-1008072-g001.jpg)
Frontiers | Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases
![A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/d41cf116-5ce2-4dfa-b26f-a01f3e331c97/gr1.jpg)
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine
![Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram](https://www.researchgate.net/publication/340506074/figure/fig1/AS:880625905049601@1586968985059/Early-and-delayed-events-in-interferon-signaling-The-recognition-of-viruses-by-cells.png)
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram
![Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus](https://www.mdpi.com/cells/cells-08-00963/article_deploy/html/images/cells-08-00963-g001.png)